Latest News and Press Releases

NEW ORLEANS, April 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 21, 2026 to file lead plaintiff applications in a...

New class action for Atara (ATRA) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/22/2026.

New class action for uniQure N.V. (QURE) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 4/13/2026.

NEW ORLEANS, April 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 13, 2026 to file lead plaintiff applications in a...

北卡罗来纳州夏洛特市, April 09, 2026 (GLOBE NEWSWIRE) -- 聚焦超声技术领域的全球领导者Sonablate今日宣布了其领导团队的重要新增成员任命，以扩大其“精准声波医学”的规模——利用靶向超声能量在不进行手术的情况下治疗疾病，同时保全患者的生活质量。 Martin (“Marty”) Wade 已获任董事会主席，Brian...

Delray Beach, FL, April 09, 2026 (GLOBE NEWSWIRE) -- The global portable ultrasound market stands at a critical growth juncture. Valued at USD 2.49 billion in 2025, the sector is projected to expand...

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm

Sonablate announced leadership team additions as it scales “precision sound medicine” using targeted ultrasound energy to treat disease without surgery.

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, announced that it is now offering access...

MMI (Medical Microinstruments, Inc.) today announced the commercial launch in the U.S. of its Robotic Suture.

LOS ANGELES, CA, April 09, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced...

AUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: Pharmaceutical manufacturing is entering a period of structural transformation as regulators impose increasingly...

DALLAS, April 09, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...

AUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: As regulatory demands intensify and production environments become more complex, pharmaceutical manufacturers are...

Austin, United States, April 09, 2026 (GLOBE NEWSWIRE) -- As per the SNS Insider Report, The Endometriosis Treatment Market size was valued at USD 2.14 billion in 2025 and is expected to reach USD...

Wegovy® injection is the first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU

Planned interim analysis from DENALI Part 2a showed a clearly differentiated response rate at 400mg QD 5:2 over 300mg QD 5:2 and comparable safety profiles between the two dose groupsAzenosertib...

BOSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with...

Lead candidate, CBT-001 for the treatment of pterygium, a multi-billion-dollar addressable market, is in mid-Phase 3 with initial topline data anticipated in Q3 2026 Second asset, CBT-004 for the...

Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer.

EMERYVILLE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a late-stage clinical biopharmaceutical company focused on developing cell therapies for...

BMC Psychiatry publication reports statistically significant reductions in self-injury behaviors and depressive symptoms, with brain-network findings further supporting Nexalin’s differentiated,...

JENA, Germany, April 09, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...

Data build on findings presented at ESMO 2025 and support potential of darlifarnib to overcome resistance and resensitize tumors to VEGFR TKI therapy Virtual investor call on April 17, 2026, at 7:30...

LOS ALTOS, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...

Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can already provide sufficient statistical power to support...

TORONTO and HOUSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company...

CAMBRIDGE, Mass., April 09, 2026 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres or the Company), a leading live biotherapeutics company, today announced that it will present at...

The financing combines a $50M Series D investment by Boehringer Ingelheim with additional dedicated funding to support commercialization. As part of the agreement, Boehringer is transferring...

• Adam Schayowitz, Ph.D., MBA appointed as Head of R&D• Scott Platshon appointed as Chief Business Officer  VANCOUVER, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc....

Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) announced that its proprietary PD-L1/4-1BB bispecific antibody,

Austin, United States, April 09, 2026 (GLOBE NEWSWIRE) -- SNS Insider reported that global Electrosurgical Devices Market size was valued at USD 8.92 billion in 2025 and is expected to reach USD...

Idorsia thanks Alberto Gimona – most recently Head of Global Clinical Development and Medical Affairs – and wishes him all the best for a well-deserved retirementAmer Joseph joins Idorsia as EVP,...

Austin, TX, USA, April 09, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Centrifugal High-Speed Separators Market Size, Trends and Insights By Type...

GLPro claims evaluated: GLP-1 blood sugar formula, bariatric gelatin trick recipe, Berberine HCL research, pricing, and 60-day guarantee reviewed.

IRVINE, Kalifornie, April 09, 2026 (GLOBE NEWSWIRE) -- iHerb, jeden z největších světových online prodejců zaměřených na zdraví a wellness, dnes oznámil uzavření exkluzivního mezinárodního...

IRVINE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- iHerb, salah satu peruncit dalam talian terbesar di dunia yang mengkhusus kepada kesihatan dan kesejahteraan, hari ini mengumumkan kerjasama...

カリフォルニア州アーバイン発, April 09, 2026 (GLOBE NEWSWIRE) -- 健康・ウェルネス分野を専門とする世界最大級のオンライン小売業者であるアイハーブ (iHerb) は本日、カイリー・ジェンナー (Kylie Jenner) が設立したk2oとの独占的国際提携を発表した。...

IRVINE, California, April 09, 2026 (GLOBE NEWSWIRE) -- iHerb, salah satu peritel online terbesar di dunia dengan spesialisasi di bidang kesehatan dan kebugaran, hari ini mengumumkan kemitraan...

IRVINE, Kalifornien, April 09, 2026 (GLOBE NEWSWIRE) -- iHerb, einer der weltweit größten Online-Händler mit Schwerpunkt auf Gesundheit und Wellness gab heute eine exklusive internationale...

SlimCrystal crystal water bottle claims evaluated: odd water secret weight loss positioning, crystal healing context, pricing, and refund details

The Soleno complaint alleges that Soleno Phase 3 clinical trial program for DCCR had downplayed, misrepresented, and/or concealed safety concerns.

Found Health's GLP-1 program, insurance check, Wegovy, Zepbound, Ozempic access, compounded options, and 2026 pricing structure — evaluated.

Investors who lost money in QURE after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

Investors who lost money in IBRX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

• Plan to resume enrollment in clinical study of lorigerlimab in gynecologic cancers   • On track to provide mid-2026 program update  ROCKVILLE, MD, April 08, 2026 (GLOBE NEWSWIRE) -- MacroGenics,...

AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness

SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in...